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Abstract

Lewis lung carcinoma (LLC) is an experimental
tumor which can be maintained
by subcutaneous
transfer
of tumor cells in C57Bl/6 mice (7, 9).
It
metastasizes
to the lungs, liver and kidneys but not
to hemopoietic
organs
(7).
However, during
the
course of the disease the spleen becomes progressively and massively enlarged
and the animals develop progressive
anemia with reticulocytosis,
suggesting hemolysis (1, 4, 5). To gain further insight
into the mechanism of this anemia, the structure
of
spleen and bone marrow of these tumor-bearing
animals was studied by light and electron microscopy.
The results support the suggestion of hemolysis and
further indicated
ineffective
erythropoiesis.
Materials
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Introduction

Lewis lung carcinoma of C57Bl/6 mice causes a
progressive
anemia
with
reticulocytosis
and
splenomegaly,
metastasizes
to lungs, liver, and kidneys but does not invade hemopoietic tissues.
The
cause of this anemia is uncertain.
We studied the
structure
of spleen and bone marrow in these tumor
hosts by light and electron microscopy.
Splenic congestion of the red pulp with numerous erythropoietic
islands
and marrow hyperplasia
characterized
the
hemopoietic
tissues
of these
mice , which,
when
coupled
with other hematological
parameters
suggested a hemolytic condition.
However, the erythropoietic response appeared to be in part ineffective
as
evidenced
by phagocytosis
of immature as well as
mature red blood cells within the spleen and marrow.
Thus, the condition of anemia in Lewis lung carcinoma may result from a multifactorial
response
of hemolysis and ineffective
erythropoiesis
and hemolysis.
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Methods

Tumor System
LLC was obtained from the Frederick
Cancer
Research
Facility
(Frederick,
MD) and has been
maintained in our laboratory by subcutaneous
implantation of 2 mm tumor fragments
every 14 days into
male C57Bl/6 mice, 18-20 grams (NCI).
The method
for its passage and maintenance
and quality control
has been described
in detail (1, 4) and will not be
repeated
here . In the present work, each mouse received a single-cell
suspension
of 106 viable LLC
cells resuspended
in Hanks' Balanced Salt Solution
(HBSS).
Our previous work has shown that the implantation
of this cell number results in 100% "take"
with a median survival of 23 days.
Control animals
received an injection of equal volume of HBSS. This
group is referred
to here as "sham controls."
Hematologic Studies
At various
times after
tumor implantation,
groups of animals (at least 5 per group) were sacrificed for hematologic
studies.
Heparinized
whole
blood was collected by cardiac puncture;
hemoglobin,
hematocrit,
reticulocyte,
total WBC, and differential
WBC counts were determined.
Reticulocyte
counts
were corrected
for the hematocrit.
Femoral bone
marrow was harvested
and total cell number per
femur was determined
and was not different
in
tumor-bearing
and control animals (1, 4); a myeloid:
erythroid
ratio was ascertained
on smears by counting 500 cells.
Splenic weight of each mouse was
recorded
at the time of marrow harvest.
Microscopic
Studies
For hght microscopy
spleen and marrow tissues
from at least 5 animals per group were fixed in 10%
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Figure 1.
Light micrograph
of a hematoxylin
and
eosm stained
section
of the spleen
of an LLCbearing
mouse 19 days post tumor implantation.
Note congestion
of the red pulp with numerous foci
of hemopoiesis . Splenic sinuses contained
evidence
of intravascul a r erythropoiesis
. (S) sinus .

Figure 2. Electron micrograph
of a section of red
pulp of a spleen from an LLC mouse 14 days post
implantation.
Erythroblastic
islands such as this one
on which a central
macrophage
forms a focus of
erythropoietic
activity
are seen throughout
the red
pulp. (E) erythroid
cell.

Table 1. Hematological parameters
in LLC mice and
sham controls
19 days post tumor implantation .

ethanol, infiltrated
with Epon 812, and embedded in
Epon 812.
The samples were cured for 3 days in
40°C and 60°C ovens and then were sectioned.
Sections of 1 micrometer
thickness
were obtained
with
glass knives stained with alkaline toluidine blue (pH
11) and ex amined by light microscopy.
Suitable areas
were then trimmed and thin sectioned
with a diamond knife in an LKB-5 microtome.
Sections were
stained with 2 . 5 % aqueous uranyl acetate for 1 h and
0. 2% lead citrate
for 5 minutes and observed
in a
JEOL 100 CX electron
microscope
(60 kV).

LLC

Sham Controls

32 , 110 ± 8200

2, 514 ± 1100

5.5 + 0.3

12 . 0 ± 0.8

Hematocrit

18 ± 1. 9

37 ± 2 . 7

Reticulocytes
(%)

8.3 ± 3.1

1.7 ± 0.7

Neutrophils
(x 10-3)

/µ l

Hemoglobin
(g / di)

Results

Marrow Myeloid:
Erythroid
Ratio
Spleen Weight
(mg)

1.5: 1

1.2 : 1

362 ± 27.9

77 ± 1. 5

formalin , buffered with phosphate buffered saline (pH
7. 4) , dehydrated
in ethanol, and embedded with paraffin . Sections (3 microns in thickness)
were stained
with hematoxylin
and eosin .
For transmission
electron
microscopy
(TE M)
spleens and marrow tissues from at least 5 animals
per group were removed, cut into small pieces about
1-2 mm which gave approximately
4 samples for processing
per tissue and fixed in 4% cold glutaraldehyde in cacodylate
buffer (pH 7 .3) overnight
at
4°C . The tissues were then post-fixed
in similarly
buffered
1% cold osmium tetroxide
for 45 minutes at
4°C . They were dehydrated
in a graded series of

Hematological
parameters
Hematological parameters
in tumor-bearing
mice
and sham controls
are shown in Table 1. LLC mice
developed significant
anemia represented
by a decline
in hemoglobin concentration
(LLC 5.5 ± 0.3 vs. control 12.0 ± 0.8) and a hematocrit
(LLC 18 ± 1.9 vs .
control 37 ± 2.7).
This anemia became apparent by day 3 (hemoglobin 10,1 ± 0 . 3 in LLC) and progressively
worsened
with growth of the tumor. Significant
reticulocytosis
also developed with counts becoming as high as 8.3 ±
3 . 1 in tumor-bearing
mice . In addition, leukocytosis
with neutrophilia
progressed
from day 3 until the
death of the animal (LLC 32,110 ± 8200, control
2,514 ± 1100),
In the bone marrow the myeloid:
erythroid
(M:E) ratio went from 1.2:1 in controls to
as high as 3 . 9:1 in LLC mice by day 7. By day 19
the M:E ratio in tumor-bearing
animals approached
that of control.
Significant
splenomegaly
developed
progressively
in LLC mice with the spleen increasing
in size about 5 times (362 ± 27 , 9 vs. 77 ± 1.5 mg).
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Figure 3. Electron micrograph of a section of bone marrow from the same mouse as the spleen in figure 2.
Erythroblastic
islands such as these were present in the marrow, with mitotic figures frequently
seen. (M)
mitosis.
Fir;ire 4. Electron micrograph of a splenic
ev idence of active intralumenal
erythropoiesis,
er ythroid cell, (End) endothelial
cell.

sinus from the spleen of a 14 day tumor-bearing
mouse . Note
with developing erythroid cells and mitoses . (M) mitosis, (E)

Figure 5. Electron micrograph of a section of splenic red pulp of an LLC mouse 11 days post implantation.
Macrophages such as this one were frequently
seen in the process of digesting hemoglobinized red cell fragments . (Mac) macrophage,
(EI) erythroid
inclusion.
Figure 6. Electron micrograph of another splenic section from an LLC mouse, 7 days post implantation.
A
nucleus as well as hemoglobinized cell fragments of an erythroid
cell have been ingested by a cordal macrophage. (EN) erythroid
nucleus.

1589

C. Hardy,

Y. Wang, B. Collier

Microscopic
findings
By light microscopy
the splenic red pulp, as
well as marrow of tumor-bearing
mice appeared
markedly congested and hypercellular,
with splenic
cords containing numerous foci of hemopoiesis (Figure 1).
This included all three lineages (erythropoiesis, granulopoiesis,
and megakaryocytopoiesis).
By comparison,
the white pulp appeared
somewhat
small and hypotrophic.
This congestion of red pulp
progressed
with growth of the tumor.
Splenic sinuses contained many mature red cells but also numerous hemopoietic foci, indicating the occurrence
of
intravascular
erythropoiesis
within the sinuses of
spleen in tumor-bearing
mice (Figure 1).
Foci of
hemopoiesis were also seen in electron microscopic
preparations
of both spleen and marrow (Figures 2,
3). Erythropoietic
foci usually could be perceived as
surrounding
a central macrophage,
thus forming an
erythroblastic
island (2). Branches of central macrophages penetrated between developing erythroid cells
which were often in the synchronous
maturational
stage.
The central macrophage often contained red
cell nuclei and sometimes entire nucleated crythroid
cells.
Mitotic figures were frequently
seen in these
islands (Figure 3).
Intravascular
erythropoiesis
was also observed
within the lumen of splenic sinuses, and again developing erythroid
cells were in synchronous
maturational
stages
and mitoses not infrequently
seen
(Figure 4).
Of much interest
was the magnitude of phagocytosis by cordal macrophages
(Figures 5, 6). This
included both hemoglobinized fragments of erythroid
cell cytoplasm as well as their nuclei and the entire
cell.
This erythrophagocytosis
was the salient feature of spleen particularly
after day 7 post implantation.
It was striking when compared to the spleen
from sham control mice.
No tumor cells were seen
in marrow or spleen at anytime during the course of
tumor development.
Discussion
The profound anemia that develops during the
course of this experimental
tumor is associated
with
progressive
reticulocytosis,
marrow hyperplasia
and
splenomegaly and suggest a hemolytic disorder . Neither the spleen nor the marrow is infiltrated
by
tumor.
This is evident not only by the absence of
tumor cells in these organs in our present
microscopic examination, but also by functional studies in
which organ cell suspensions
are subcutaneously
im planted in new hosts.
These implants never lead to
tumor production.
Hence, splenomegaly and marrow
hyperplasia,
observed in this study, should be interpreted in the context of anemia and other hematologic abnormalities
as outlined in Table 1.
In other experimental
tumors, Wieman et al.
(10) have shown the production
of a hemolytic substance which can lyse normal red cells in vitro.
Similarly, in clinical situations,
hemolytic anemias
are frequently
associated with the presence of solid
tumors (3, 6, 8) as well as hematological
malignancies.
Further studies on the mechanism of hemolysis
in this experimental
tumor may shed some light on
the mechanism of tumor-associated
hemolytic disease
in humans.
Of further
interest
in this study was that
erythropoietic
response to hemolysis appeared to be
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at least in part ineffective.
This is evident
by
phagocytosis
of immature cells in spleen as well as
bone marrow.
The reason for this ineffective
erythropoiesis is not clear.
It is possible, however, that
the hemolytic factor responsible
for destruction
of
mature cells may extend its effect to immature ones,
thus leading to ineffective
erythropoiesis.
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Discussion

with Reviewers

H. Gamliel: If Lewis lung carcinoma invades the liver
and kidneys too, why was "lung" (and not liver, etc.)
attributed
to this type of carcinoma?
Can you speculate on why LLC invades the lungs, liver, and kidneys but not hemopoietic tissues?
Studies of such a
kind might contribute
a lot in shedding more light
on the mechanism of tumor infiltration.
Are you
aware of such studies?
Authors: This is a very interesting
question.
LLC
can potentially
provide an excellent model to study
the mechanism of metastasis in solid tumors.
This is
because of its highly predictable
pattern
of metastasis.
However, to our knowledge, this model system has not been adequately exploited.
Lung, (rather than liver and kidney)
metastasis
is generally
emphasized because it is the earliest and most predictable one.
We feel this occurs because of the
invasion of the venous system for which the lung is
the first stop in the course of circulation.
H. Gamliel: It seems that the description
of erythropoietic
foci surrounding
a central macrophage is
referring
to the spleen only.
If this is correct, are
there comparable patterns
of formation of such foci
in the bone marrow?
Authors: Yes, both tissues are involved.

Authors: Probably ineffective hemopoiesis involves all
three cell lines (erythropoiesis
as well as granulopoiesis and megakaryocytopoiesis).
However, the
magnitude of granulopoiesis
is so intense that the
net result is blood granulocytosis.
This intense
granulopoiesis
can be attributed
to growth factor
production by tumor cells as we have reported before
( 1, 4).

The mechanism of thrombocytopenia
has always
intrigued
us.
How much ineffective
thrombocytopoiesis contributes
to this is not known. This is an
area that is currently
under study.
T. Seed: Is the early rise (at 7 days) in the M/E
raho due to enhanced granulopoiesis
or suppressed
erythropoiesis,
or both?
Authors: This is due to enhanced granulopoiesis.
We
have previously
reported (1,4) on this aspect.
Enhanced granulopoiesis
in the course of this tumor is
biphasic,
with early and late phases.
Both are the
result of the production
of GM-CSF and M-CSF by
the tumor .
T. Seed: Can LLC cells (or their soluble products)
directly
mediate,
in vitro,
similar proliferative/
suppressive
responses?
Authors: Yes. We have developed a cloned cell line
from this tumor under serum-free
conditions.
Our
data, as yet unpublished,
indicate the elaboration of
granulopoietic
factors by this cell line.
Whether
there is a suppressive
factor as well is currently
under study.

H. Gamliel: There is only limited information on the
microstructure
of the bone marrow in the studied
samples.
Compared to the describe changes in red
and white pulp of the spleen, are there any such
c hanges in the stroma of the bone marrow?
Authors:
We have not observed
such changes and
co nsequently
we have not described
any.
H. Gamliel: Did you notice any macrophages or mac rophage "branches"
in close relation to granulopoiesis or megakaryocytopoiesis
foci? Did you ever
see fragments of myeloid or mega cells in the macrophages' cytoplasm?
If not, what were your criteria
for differentiating
between immature erythroid
fragments and pieces from other immature blood cells?
Compared to the "ineffective
erythropoiesis,"
would
you say that the mega- and/or granulopoiesis
were
(super) effective,
as might be indicated in Table 1?
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M. Kashimura : Congestion is usually used when venous blood stagnates.
I doubt whether congestion is
a proper word when the red pulp is occupied with
erythrobl as tic islands.
Authors : This definition could be applicable to those
organs where the circulation
is closed.
In spleen
with its characteristically
open circulation,
the
situation
is entirely
different.
Here the term has
been used in any condition that leads to blockage of
cordal pathways .

